| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 May; 31(4):263-98.
Abstract | Full Citation |
| Schrier RW, Masoumi A, Elhassan E
Role of Vasopressin and Vasopressin Receptor Antagonists in Type I Cardiorenal Syndrome. [JOURNAL ARTICLE]
Blood Purif 2009; 27(1):28-32.
Abstract | Full Citation | Find Related Articles |
| Arai Y, Fujimori A, Sasamata M, et al.
New Topics in Vasopressin Receptors and Approach to Novel Drugs:Research and Development of Conivaptan Hydrochloride (YM087), a Drug for the Treatment of Hyponatremia. [JOURNAL ARTICLE]
J Pharmacol Sci 2009; 109(1):53-59.
Abstract | Full Citation | Find Related Articles |
| Murphy T, Dhar R, Diringer M
Conivaptan Bolus Dosing for the Correction of Hyponatremia in the Neurointensive Care Unit. [JOURNAL ARTICLE]
Neurocrit Care 2009 Jan 4.
Abstract | Full Citation | Find Related Articles |
| Oghlakian G, Klapholz M
Vasopressin and vasopressin receptor antagonists in heart failure. [Journal Article]
Cardiol Rev 2009 Jan-Feb; 17(1):10-5.
Abstract | Full Citation |
| de Arruda Camargo GM, de Arruda Camargo LA, Saad WA
Medial septal area vasopressin receptor subtypes in the regulation of urine and sodium excretion in rats. [JOURNAL ARTICLE]
J Neuroendocrinol 2008 Dec 6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Annane D, Decaux G, Smith N
Efficacy and Safety of Oral Conivaptan, a Vasopressin-Receptor Antagonist, Evaluated in a Randomized, Controlled Trial in Patients With Euvolemic or Hypervolemic Hyponatremia. [JOURNAL ARTICLE]
Am J Med Sci 2008 Dec 3.
Abstract | Full Citation | Find Related Articles |
| Wright WL, Asbury WH, Gilmore JL, et al.
Conivaptan for Hyponatremia in the Neurocritical Care Unit. [JOURNAL ARTICLE]
Neurocrit Care 2008 Nov 12.
Abstract | Full Citation |
| Filippatos G, Parissis JT
Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy? [Editorial]
J Card Fail 2008 Oct; 14(8):648-50.
Full Citation | Find Related Articles |
| Goldsmith SR, Elkayam U, Haught WH, et al.
Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study. [Journal Article]
J Card Fail 2008 Oct; 14(8):641-7.
Abstract | Full Citation | Find Related Articles |
  |
